← Back to directory

Guido Reifenberger

Researcher Next ID · RN-029242

Researcher · Medicine

Düsseldorf University Hospital

Düsseldorf, Germany

Not currently recruitingFunding unknown
Works count
1,198
Citation count
112,058
H-index
137
i10-index
408

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Glioma Diagnosis and Treatment
Epigenetics and DNA Methylation
Brain Metastases and Treatment
Cancer Genomics and Diagnostics
Cancer, Hypoxia, and Metabolism

Publications

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

    Neuro-Oncology · 2021 · https://doi.org/10.1093/neuonc/noab106

  • EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

    Nature Reviews Clinical Oncology · 2020 · https://doi.org/10.1038/s41571-020-00447-z

  • Molecular targeted therapy of glioblastoma

    Cancer Treatment Reviews · 2019 · https://doi.org/10.1016/j.ctrv.2019.101896

  • cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

    Acta Neuropathologica · 2018 · https://doi.org/10.1007/s00401-018-1913-0

  • European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30194-8

  • Advances in the molecular genetics of gliomas — implications for classification and therapy

    Nature Reviews Clinical Oncology · 2016 · 10.1038/nrclinonc.2016.204

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

    Acta Neuropathologica · 2016 · https://doi.org/10.1007/s00401-016-1545-1

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Cell · 2016 · 10.1016/j.cell.2016.01.015

  • Glioblastoma: pathology, molecular mechanisms and markers

    Acta Neuropathologica · 2015 · 10.1007/s00401-015-1432-1

  • Glioma

    Nature Reviews Disease Primers · 2015 · 10.1038/nrdp.2015.17

  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

    Nature · 2014 · 10.1038/nature13379

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Cancer Cell · 2014 · 10.1016/j.ccr.2014.02.004

  • EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

    The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70011-7

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    Nature Genetics · 2013 · 10.1038/ng.2682

  • Dissecting the genomic complexity underlying medulloblastoma

    Nature · 2012 · 10.1038/nature11284

  • Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

    The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70164-x

  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

    Nature · 2012 · https://doi.org/10.1038/nature10833

  • Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma

    Cancer Cell · 2012 · 10.1016/j.ccr.2012.08.024

  • Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

    Acta Neuropathologica · 2011 · 10.1007/s00401-011-0802-6

  • Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

    Acta Neuropathologica · 2010 · 10.1007/s00401-010-0781-z

  • MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

    Nature Reviews Neurology · 2009 · 10.1038/nrneurol.2009.197

  • NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

    Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.23.6497

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

    Acta Neuropathologica · 2009 · 10.1007/s00401-009-0561-9

  • Long-term survival with glioblastoma multiforme

    Brain · 2007 · 10.1093/brain/awm204

  • The WHO Classification of Tumors of the Nervous System

    Journal of Neuropathology & Experimental Neurology · 2002 · https://doi.org/10.1093/jnen/61.3.215

Current projects

    No projects listed.